Title:
A pivotal Phase III, open-label, randomized, controlled multi-center study of the efficacy of L19IL2/L19TNF neoadjuvant intratumoral treatment followed by surgery versus surgery alone in clinical stage III B/C melanoma patients.
Phase:
III
Contact:
Silvia Koerner / (Study Nurse)
Email-Address:
silvia.koerner@med.uni-heidelberg.de
Clinical Investigator:
Prof. Dr. Jessica Hassel
Registration:
Keine Registernummer angegeben.
EudraCT-Number:
siehe EU klinisches Studienregister
2015-002549-72